Your browser doesn't support javascript.
loading
Effects of Transient and Persistent Anti-drug Antibodies to Certolizumab Pegol: Longitudinal Data from a 7-Year Study in Crohn's Disease.
Sandborn, William J; Wolf, Douglas C; Kosutic, Gordana; Parker, Gerry; Schreiber, Stefan; Lee, Scott D; Abraham, Bincy; Afzali, Anita; Arsenescu, Razvan I; Gutierrez, Alexandra; Spearman, Marshall; Coarse, Jason; Feagan, Brian G.
Afiliación
  • Sandborn WJ; *Division of Gastroenterology, University of California San Diego, La Jolla, California; †Atlanta Gastroenterology Associates, Atlanta, Georgia; ‡UCB Pharma, Raleigh, North Carolina; §GPmax Consulting Ltd., Slough, United Kingdom; ‖Department of Internal Medicine and Institute for Clinical Molecular Biology, Christian-Albrechts University, Kiel, Germany; ¶Clinical Inflammatory Bowel Disease Program, University of Washington Digestive Disease Center, Seattle, Washington; **Department of Medicine,
Inflamm Bowel Dis ; 23(7): 1047-1056, 2017 07.
Article en En | MEDLINE | ID: mdl-28410341

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Certolizumab Pegol / Anticuerpos Monoclonales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Inflamm Bowel Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2017 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Certolizumab Pegol / Anticuerpos Monoclonales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Inflamm Bowel Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2017 Tipo del documento: Article Pais de publicación: Reino Unido